 Leah Villegas
Concepts (93)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fructose | 1 | 2018 | 132 | 0.540 |
Why?
| | Hypoxia | 4 | 2014 | 1199 | 0.390 |
Why?
| | Metalloporphyrins | 1 | 2013 | 63 | 0.370 |
Why?
| | Pulmonary Artery | 4 | 2015 | 1127 | 0.350 |
Why?
| | Inflammasomes | 1 | 2013 | 145 | 0.340 |
Why?
| | Hypertension, Pulmonary | 4 | 2015 | 1957 | 0.310 |
Why?
| | Liver | 1 | 2018 | 1895 | 0.310 |
Why?
| | Superoxide Dismutase | 4 | 2015 | 303 | 0.290 |
Why?
| | Carrier Proteins | 1 | 2013 | 733 | 0.280 |
Why?
| | Half-Life | 1 | 2018 | 153 | 0.140 |
Why?
| | Biological Availability | 1 | 2018 | 144 | 0.140 |
Why?
| | Area Under Curve | 1 | 2018 | 329 | 0.130 |
Why?
| | Rats, Wistar | 1 | 2018 | 449 | 0.130 |
Why?
| | ROC Curve | 1 | 2018 | 619 | 0.120 |
Why?
| | Administration, Oral | 1 | 2018 | 863 | 0.120 |
Why?
| | National Heart, Lung, and Blood Institute (U.S.) | 1 | 2016 | 103 | 0.120 |
Why?
| | Financing, Government | 1 | 2016 | 53 | 0.120 |
Why?
| | Education | 1 | 2016 | 105 | 0.110 |
Why?
| | Research Personnel | 1 | 2016 | 187 | 0.100 |
Why?
| | Bleomycin | 1 | 2015 | 253 | 0.100 |
Why?
| | Vascular Remodeling | 1 | 2015 | 209 | 0.100 |
Why?
| | Myocytes, Smooth Muscle | 2 | 2013 | 266 | 0.100 |
Why?
| | Glucose | 1 | 2018 | 1039 | 0.100 |
Why?
| | Intestinal Mucosa | 1 | 2018 | 675 | 0.090 |
Why?
| | Pulmonary Alveoli | 1 | 2015 | 383 | 0.090 |
Why?
| | Caspase 1 | 1 | 2013 | 146 | 0.090 |
Why?
| | Rats | 2 | 2018 | 5581 | 0.090 |
Why?
| | PTEN Phosphohydrolase | 1 | 2013 | 164 | 0.090 |
Why?
| | Early Growth Response Protein 1 | 1 | 2011 | 32 | 0.090 |
Why?
| | Xanthine Oxidase | 1 | 2011 | 79 | 0.090 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2013 | 168 | 0.090 |
Why?
| | Interleukin-18 | 1 | 2013 | 234 | 0.090 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2011 | 174 | 0.080 |
Why?
| | Interleukin-1beta | 1 | 2013 | 390 | 0.080 |
Why?
| | Bronchopulmonary Dysplasia | 1 | 2015 | 411 | 0.080 |
Why?
| | cdc42 GTP-Binding Protein | 1 | 2009 | 21 | 0.080 |
Why?
| | Monomeric GTP-Binding Proteins | 1 | 2009 | 15 | 0.080 |
Why?
| | Pneumocystis carinii | 1 | 2009 | 12 | 0.080 |
Why?
| | Biomedical Research | 1 | 2016 | 718 | 0.070 |
Why?
| | Endothelial Cells | 1 | 2015 | 866 | 0.070 |
Why?
| | Fungal Proteins | 1 | 2009 | 146 | 0.070 |
Why?
| | Reactive Oxygen Species | 1 | 2011 | 602 | 0.070 |
Why?
| | Up-Regulation | 1 | 2011 | 848 | 0.070 |
Why?
| | Animals | 6 | 2018 | 38141 | 0.070 |
Why?
| | Blood Glucose | 1 | 2018 | 2330 | 0.070 |
Why?
| | Gene Expression | 1 | 2013 | 1478 | 0.070 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2009 | 456 | 0.060 |
Why?
| | Hypertrophy, Right Ventricular | 2 | 2015 | 149 | 0.050 |
Why?
| | Nitric Oxide Synthase Type III | 2 | 2015 | 203 | 0.050 |
Why?
| | Mice | 4 | 2014 | 18338 | 0.050 |
Why?
| | Male | 5 | 2018 | 72817 | 0.050 |
Why?
| | Animals, Newborn | 2 | 2015 | 890 | 0.040 |
Why?
| | Mice, Knockout | 2 | 2015 | 3125 | 0.030 |
Why?
| | Oxidative Stress | 2 | 2015 | 1350 | 0.030 |
Why?
| | Ventricular Pressure | 1 | 2015 | 52 | 0.030 |
Why?
| | Vascular Endothelial Growth Factor Receptor-2 | 1 | 2015 | 86 | 0.030 |
Why?
| | Soluble Guanylyl Cyclase | 1 | 2014 | 15 | 0.030 |
Why?
| | GTP Cyclohydrolase | 1 | 2014 | 10 | 0.030 |
Why?
| | Cyclic Nucleotide Phosphodiesterases, Type 5 | 1 | 2014 | 23 | 0.030 |
Why?
| | Guanylate Cyclase | 1 | 2014 | 38 | 0.030 |
Why?
| | Estrogen Antagonists | 1 | 2014 | 37 | 0.030 |
Why?
| | Cyclic GMP | 1 | 2014 | 90 | 0.030 |
Why?
| | Minority Groups | 1 | 2016 | 283 | 0.030 |
Why?
| | Tamoxifen | 1 | 2014 | 191 | 0.030 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2014 | 207 | 0.020 |
Why?
| | Ventricular Function, Right | 1 | 2015 | 296 | 0.020 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2015 | 550 | 0.020 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2015 | 248 | 0.020 |
Why?
| | Signal Transduction | 2 | 2015 | 5202 | 0.020 |
Why?
| | Extracellular Space | 1 | 2011 | 119 | 0.020 |
Why?
| | Phosphorylation | 1 | 2015 | 1707 | 0.020 |
Why?
| | Nitric Oxide | 1 | 2015 | 894 | 0.020 |
Why?
| | MAP Kinase Signaling System | 1 | 2011 | 306 | 0.020 |
Why?
| | Guanosine Triphosphate | 1 | 2009 | 89 | 0.020 |
Why?
| | RNA, Small Interfering | 1 | 2011 | 632 | 0.020 |
Why?
| | Cattle | 1 | 2011 | 977 | 0.020 |
Why?
| | Oxidation-Reduction | 1 | 2011 | 1080 | 0.020 |
Why?
| | Blood Pressure | 1 | 2014 | 1782 | 0.020 |
Why?
| | Phenotype | 1 | 2015 | 3157 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2015 | 2355 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2009 | 2137 | 0.010 |
Why?
| | Chronic Disease | 1 | 2011 | 1816 | 0.010 |
Why?
| | Disease Progression | 1 | 2013 | 2862 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 2009 | 2910 | 0.010 |
Why?
| | Severity of Illness Index | 1 | 2013 | 2945 | 0.010 |
Why?
| | Mice, Inbred C57BL | 1 | 2015 | 5989 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2011 | 2499 | 0.010 |
Why?
| | Apoptosis | 1 | 2011 | 2411 | 0.010 |
Why?
| | Lung | 1 | 2014 | 4103 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2011 | 4559 | 0.010 |
Why?
| | United States | 1 | 2016 | 16115 | 0.010 |
Why?
| | Humans | 3 | 2016 | 145491 | 0.010 |
Why?
| | Female | 1 | 2016 | 78763 | 0.000 |
Why?
|
|
Villegas's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|